中國：採購東芝重離子治療設備
– 東芝 ESS 與 Ion Nova 簽署業務合作協議
– 中國新增約450萬癌症患者
我們提供《核能工業報》上發表的文章摘要。
Toshiba Energy Systems: (Toshiba ESS)
On November 6th, we concluded a business partnership agreement for the sale of heavy ion beam therapy equipment in China.
The company aims to receive orders for the first machine in the Chinese market as soon as possible.
Ion Nova: China Ai Lili (Shanghai) Medical Science and Technology Co., Ltd.
It is made up of experts in heavy ion beam therapy equipment. A company specializing in equipment sales.
APTR:
The only company that has received approval from the Chinese government to manufacture and sell proton beam therapy equipment made in China.
Cancer patients in China:
Approximately 4.5 million new cancer patients (as of 2020).
Providing appropriate cancer treatment is an urgent national issue.
Heavy ion radiotherapy in China:
Currently, there are only two heavy ion radiotherapy facilities in China.
By 2025, heavy ion beams and proton beams will be permitted to be installed in 41 locations.
Heavy ion beam therapy equipment places less physical burden on patients during treatment.
Toshiba ESS: National Institute for Quantum Science and Technology
The two companies jointly developed a heavy ion radiotherapy device.
Heavy ion radiotherapy facilities are now rapidly spreading around the world.
Japanese Institute of Radiology:
In 2016, the Institute of Radiological Sciences (Chiba City) adopted superconducting electromagnets for the first time in the world.
We have delivered a smaller and lighter heavy ion beam rotating gantry.
Yonsei University in South Korea:
The device was delivered to Yonsei University in South Korea, and treatment began in April 2023.
Overseas as well, our delivery track record and technical capabilities have been highly evaluated.
Now accepting orders in the US:
We have started accepting orders in the United States, where needs are increasing.
We hope to achieve even higher functionality and contribute to high-quality cancer treatment.
https://www.jaif.or.jp/journal/japan/20333.html
Toshiba and Ion Nova of China Sign Business Alliance Agreement
for Sales of Heavy Ion Therapy Equipment
News Release | Toshiba Energy Systems & Solutions
Toshiba Energy Systems & Solutions Corporation (Toshiba ESS)
today announced that on November 6 it signed a business alliance agreement with China-based Ion Nova (Shanghai) Medical Technology Co., Ltd. (Ion Nova)
for the sales of heavy ion therapy equipment*1 in China.
Heavy ion therapy equipment:
A type of external radiation therapy in which carbon ions are accelerated
to about 70% of the speed of light to produce beams of carbon ions (heavy ion beams),
which are used to irradiate cancer tumors from outside the body.
Heavy ion beams：
do not propagate easily in the body,
allowing them to be focused with pinpoint accuracy on cancer tumors,
and thus are less likely to damage the surrounding normal cells.
In addition,
these beams are characterized by their ability to destroy cancer cell genes more effectively than other types of radiation.
As such, this is considered a treatment method that places minimal physical burden
on patients and allows them to return to everyday life as soon as possible.
https://www.global.toshiba/ww/news/energy/2023/11/news-20231107-01.html